Keyphrases
Glycogen Synthase Kinase 3 (GSK3)
100%
Cytotoxicity
100%
Rotenone
100%
Microtubule Destabilization
100%
Microtubules
33%
SB216763
33%
Tubulin
16%
Taxol
16%
Tau Expression
16%
Morphological Changes
8%
Glycogen Synthase kinase-3 Inhibitors
8%
Alzheimer's Disease
8%
Concomitant Treatment
8%
Dopaminergic Neuron Loss
8%
SH-SY5Y Cells
8%
Parkinson's Disease Model
8%
Tauopathy
8%
Phosphorylated tau
8%
Binding Capacity
8%
Cell Culture Model
8%
Polymerized
8%
Microtubule-associated Protein
8%
Tau Phosphorylation
8%
Microtubule Stabilizer
8%
Mitochondrial Complex I Inhibitor
8%
Animal Culture
8%
Neuroscience
Glycogen Synthase Kinase 3
100%
Cytotoxicity
100%
Microtubule
100%
Rotenone
100%
Paclitaxel
16%
Tubulin
16%
Cell Culture
8%
Parkinson's Disease
8%
Glycogen Synthase Kinase 3 Inhibitor
8%
Alzheimer's Disease
8%
Dopaminergic
8%
Microtubule Associated Protein
8%
Tauopathy
8%
NADH Dehydrogenase (Ubiquinone)
8%
Pharmacology, Toxicology and Pharmaceutical Science
Glycogen Synthase Kinase 3
100%
Rotenone
100%
Cytotoxicity
100%
2 (2,4 Dichlorophenyl) 3 (1 Methyl 3 Indolyl)maleimide
33%
Paclitaxel
16%
Tubulin
16%
Cell Culture
8%
Alzheimer's Disease
8%
Parkinson's Disease
8%
Dopamine Receptor Stimulating Agent
8%
Tauopathy
8%
Microtubule Associated Protein
8%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
8%
Glycogen Synthase Kinase 3 Inhibitor
8%
Biochemistry, Genetics and Molecular Biology
Glycogen Synthase Kinase 3
100%
Cytotoxicity
100%
Rotenone
100%
Tau
58%
Tubulin
16%
Cell Culture
8%
Morphology
8%
Dopaminergic
8%
Microtubule-Associated Protein
8%
Cytosolic Fraction
8%